2.2. PHYSICAL AND PHYSICOCHEMICAL METHODS
size. Nephelometric measurements are more reliable in low turbidity ranges, where there is a linear relationship between nephelometric turbidity unit (NTU) values and relative detector ... concentration is obtained when the particle sizes are uniform and homogeneous in the suspension. This is true only in very
Download 2.2. PHYSICAL AND PHYSICOCHEMICAL METHODS
Information
Domain:
Source:
Link to this page:
Documents from same domain
<1117> MICROBIOLOGICAL BEST LABORATORY …
www.drugfuture.com708 〈1117〉 Microbiological Best Laboratory Practices / General Information USP 35 glassware or from prior materials used in the glassware. Be Media should be labeled properly with batch or lot num-
<1227> VALIDATION OF MICROBIAL RECOVERY …
www.drugfuture.comUSP 35 General Information / 〈1227〉 Validation of Microbial Recovery 883 〈1227〉 VALIDATION OF culture preparation. The conditions of organism preparation and storage must be standardized for the neutralizer evalua-MICROBIAL RECOVERY FROM tion and should reflect the conditions of the antimicrobial
2.2.32. LOSS ON DRYING - 药物在线-快捷药物信息 …
www.drugfuture.com2.2.33. Nuclear magnetic resonance spectrometry EUROPEAN PHARMACOPOEIA 7.0 01/2009:20233 2.2.33. NUCLEAR MAGNETIC RESONANCE SPECTROMETRY INTRODUCTION Nuclearmagneticresonance(NMR)spectrometryisananalytical
2.2.46. CHROMATOGRAPHIC SEPARATION …
www.drugfuture.com2.2.45. Supercritical fluid chromatography EUROPEAN PHARMACOPOEIA 7.0 Control solutions.In addition to the TOC water control, prepare suitable blank solutions or other solutions needed for establishing the baseline or for calibration adjustments
2.6.12. MICROBIOLOGICAL - DrugFuture
www.drugfuture.com2.6.12. Microbial enumeration tests EUROPEAN PHARMACOPOEIA 7.0 Table 2.6.12.-1. – Preparation and use of test micro-organisms Growth …
2.4. LIMIT TESTS - DrugFuture
www.drugfuture.comEUROPEAN PHARMACOPOEIA 7.0 2.4.4. Chlorides 2.4. LIMIT TESTS 01/2008:20401 2.4.1. AMMONIUM Unlessotherwiseprescribed,usemethodA. METHOD A ...
2.2. PHYSICAL AND PHYSICOCHEMICAL METHODS
www.drugfuture.com2.2.2. Degree of coloration of liquids EUROPEAN PHARMACOPOEIA 7.0 dilute suspensions containing small particles. Linearity between turbidity and concentration must be established by constructing
EUROPEAN PHARMACOPOEIA 7 - DrugFuture
www.drugfuture.com2.2.25. Absorption spectrophotometry, ultraviolet and visible EUROPEAN PHARMACOPOEIA 7.0 acquired using suitable purged instruments or ensuring that sample and background single beam spectra are acquired under
5.1.3. EFFICACY OF ANTIMICROBIAL PRESERVATION
www.drugfuture.comEUROPEAN PHARMACOPOEIA 7.0 5.1.3. Efficacy of antimicrobial preservation suspensions may be presented in sealed ampoules. Biological indicators are prepared in such a way that they can be stored
<1151> PHARMACEUTICAL DOSAGE FORMS - …
www.drugfuture.com766 〈1151〉 Pharmaceutical Dosage Forms / General Information USP 35 Figure 1. Compendial Taxonomy for Pharmaceutical Dosage Forms. volumes recommended in the accompanying table are usu- Identification—Identification tests are discussed in the
Related documents
Guidance on respiratory - HSE
www.hse.gov.ukambient particle counting; controlled negative pressure (CNP). The fit factor, which is calculated by the fit test equipment, uses the following formulas: For the ambient particle counting method, the quantitative fit factor (QNFF) is calculated as the ratio of the two aerosol concentrations measurements as shown in formula (1): QNFF =